title: EGFR expression in primary squamous cell carcinoma of the thyroid.
abstract: We present the case of a 57-year-old male with primary squamous cell carcinoma of the thyroid (PSCCT). Epidermal growth factor receptor (EGFR) staining was strongly positive. Pharmaceuticals targeting EGFR may provide an additional therapeutic option for this rare disease with extremely poor prognosis.
authors.affiliation: Division of Head and Neck Surgery, University of California-Los Angeles, California, USA. jlong@mednet.ucla.edu
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Long
authors.forename: Ali M
authors.initials: AM
authors.lastname: Strocker
authors.forename: Marilene B
authors.initials: MB
authors.lastname: Wang
authors.forename: Keith E
authors.initials: KE
authors.lastname: Blackwell
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D066246:ErbB Receptors / Q000378:metabolism*; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D013965:Thyroidectomy
chemical_list: D066246:ErbB Receptors